Newsroom
April 19, 2022
Thanks to international collaboration, more genetic variations for Alzheimer’s disease are known today than ever before. The list of gene variants recognized for late-onset Alzheimer’s grew from one in 2009 to 40 in 2022. This month, scientists published a list of 75, some of which are considered as prime drug targets. Drug development is underway. […]
April 13, 2022
mRNA quality control identified as novel drug target for Alzheimer’s and related dementias Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (April 13, 2022) — Researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) today reported the discovery of a novel mechanism by which pathological forms of tau […]
February 1, 2022
Deep brain stimulation targets memory-forming circuits. Media contacts: Will Sansom, UT Health San Antonio, (210) 567-2579, sansom@uthscsa.edu Elizabeth Allen, University Health, (210) 358-2344, elizabeth.allen@uhs-sa.com SAN ANTONIO (Feb. 1, 2021) — The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and clinical partner University Health are among 27 sites worldwide […]
December 30, 2021
Catch up on the inspiring first five episodes of Season 1 after listening to the New Name, New Season trailer, available now at Twenty-Four Seven Home Page | TPR. The Texas Public Radio podcast, “Twenty-Four Seven: A Podcast About Caregiving,” presents a thoughtful and helpful tool offering guidance to families and friends with loved ones experiencing dementia. […]
December 22, 2021
This vignette about Dr. Sudha Seshadri, professor of neurology and founding director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, is included in this San Antonio Express-News feature titled “Fascinating locals from 2021: From politicians to pandemic heroes.” Read here
December 17, 2021
Emerging evidence suggests it may be possible to treat Alzheimer’s disease by targeting therapy at senescent cells in the brain.
